 |
|
|
|
 |
|
|
| Article 1 to 10 out of 23 concerning National Cancer Institute (NCI)
|
-
New approach to immune cell analysis seen as first step to better distinguish health and disease
(11 Mar 2010)
Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human ...
-
Kill the cancer, not the patient: New toxicity testing approach could make chemo drugs safer
(23 Nov 2009)
National Cancer Institute grants $1M to test 3 chemo drugs
For cancer patients on chemotherapy, the "cure" can be as deadly as the disease itself. Adverse drug reactions are one of the leading causes of death among patients receiving cancer treatment. Jackson Laboratory Professor Gary Churchill wants to ...
-
Scientists identify gene that predicts post-surgical survival from brain metastasis of breast cancer patients
(03 Sep 2009)
Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research.Diane Palmieri, Ph.D., a staff scientist at the NCI, said ...
-
Gene transcribing machine takes halting, backsliding trip along the DNA
(03 Aug 2009)
The body's nanomachines that read our genes don't run as smoothly as previously thought, according to a new study by University of California, Berkeley, scientists. When these nanoscale protein machines encounter obstacles as they move along the ...
-
Bavarian Nordic: Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
(09 Oct 2008)
125 Patient, Prospective Randomized Placebo-Controlled Phase II Study
Bavarian Nordic has now evaluated the mature phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in the US.The ...
-
Bavarian Nordic announces partnership with National Cancer Institute in the US and obtains rights to a new vaccine candidate
(14 Aug 2008)
Bavarian Nordic's US subsidiary, BN ImmunoTherapeutics has entered into a scientific partnership with the National Cancer Institute (NCI) in the United States. Under the Cooperative Research and Development Agreement (CRADA) the NCI and Bavarian ...
-
Domestic cat genome sequenced
(01 Nov 2007)
A report that appears in the scientific journal Genome Research details the first assembly, annotation, and comparative analysis of the domestic cat genome (Felis catus). The DNA of a 4-year-old Abyssinian cat named Cinnamon, whose well-documented ...
-
US National Cancer Institute to test seven novel cancer drugs from Clavis Pharma
(29 May 2007)
Clavis Pharma announced that the US National Cancer Institute has accepted seven new compounds from the company for testing under its Developmental Therapeutics Program. The drug candidates, which are structurally novel analogues of several cancer ...
-
U.S. NCI Files for Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN
(16 May 2007)
Oncolytics Biotech Inc. announced that the U.S. National Cancer Institute (NCI) has filed a protocol with the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical trial for patients with metastatic melanoma using systemic administration of ...
-
TopoTarget and CuraGen Initiate NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
(16 Nov 2006)
TopoTarget A/S and CuraGen Corporation announced the initiation of patient dosing in a Phase II clinical trial evaluating the antitumor activity of intravenous PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of ...
|
|
|
|
|
Top